Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InspireMD (NSPR) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $73.5 million.

  • InspireMD's Shares Outstanding (Weighted Average) rose 5188.63% to $73.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.5 million, marking a year-over-year increase of 5188.63%. This contributed to the annual value of $41.9 million for FY2024, which is 7277.09% up from last year.
  • Per InspireMD's latest filing, its Shares Outstanding (Weighted Average) stood at $73.5 million for Q3 2025, which was up 5188.63% from $51.0 million recorded in Q2 2025.
  • In the past 5 years, InspireMD's Shares Outstanding (Weighted Average) registered a high of $73.5 million during Q3 2025, and its lowest value of $6.1 million during Q1 2021.
  • In the last 5 years, InspireMD's Shares Outstanding (Weighted Average) had a median value of $21.1 million in 2023 and averaged $25.4 million.
  • As far as peak fluctuations go, InspireMD's Shares Outstanding (Weighted Average) skyrocketed by 188658.35% in 2021, and later soared by 127.97% in 2022.
  • Over the past 5 years, InspireMD's Shares Outstanding (Weighted Average) (Quarter) stood at $7.3 million in 2021, then rose by 7.16% to $7.9 million in 2022, then skyrocketed by 208.29% to $24.3 million in 2023, then soared by 72.77% to $41.9 million in 2024, then skyrocketed by 75.22% to $73.5 million in 2025.
  • Its last three reported values are $73.5 million in Q3 2025, $51.0 million for Q2 2025, and $50.0 million during Q1 2025.